Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew N Freedman

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
American Journal of Medical Genetics. Part A|April 6, 2005
Physician exposure to and attitudes toward advertisements for genetic tests for inherited cancer susceptibilitySusan Thomas Vadaparampil, Louise Wideroff, Lorayn Olson, et al.
Journal of the National Cancer Institute. Monographs|August 7, 2024
Overview of cancer patient perspectives on cannabis use during treatmentKathy J Helzlsouer, Sonia M Rosenfield, Andrew N Freedman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 10, 2015
Opportunities for translational epidemiology: the important role of observational studies to advance precision oncologyMichael Marrone, Richard L Schilsky, Geoff Liu, et al.
Community Genetics|July 9, 2004
Awareness of genetic testing for increased cancer risk in the year 2000 National Health Interview SurveyLouise Wideroff, Susan Thomas Vadaparampil, Nancy Breen, et al.
Pharmacogenetics and Genomics|April 9, 2016
Dosing recommendations for pharmacogenetic interactions related to drug metabolismKelly K Filipski, Michael A Pacanowski, Anuradha Ramamoorthy, et al.
Cancer Causes & Control : CCC|October 2, 2009
The impact of changes in hormone therapy on breast cancer incidence in the US populationNathan J Coombs, Kathleen A Cronin, Richard J Taylor, et al.
JCO Precision Oncology|September 27, 2021
Distribution of Genomic Testing Resources by Oncology Practice and Rurality: A Nationally Representative StudyBrittany Gardner, Michelle Doose, Janeth I Sanchez, et al.
Expert Opinion on Drug Safety|July 8, 2014
Commonly used diabetes and cardiovascular medications and cancer recurrence and cancer-specific mortality: a review of the literatureJennifer W Wu, Denise M Boudreau, Yikyung Park, et al.
Plos Currents|June 7, 2014
Multi-marker Solid Tumor Panels Using Next-generation Sequencing to Direct Molecularly Targeted TherapiesMichael Marrone, Kelly K Filipski, Elizabeth M Gillanders, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 4, 2025
NCI-Funded Cancer Epidemiology Survivor Cohorts: Overview, Progress, and OpportunitiesLisa Gallicchio, Andrea N Burnett-Hartman, Kelly K Filipski, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
American Journal of Medical Genetics. Part A|April 6, 2005
Physician exposure to and attitudes toward advertisements for genetic tests for inherited cancer susceptibilitySusan Thomas Vadaparampil, Louise Wideroff, Lorayn Olson, et al.
Journal of the National Cancer Institute. Monographs|August 7, 2024
Overview of cancer patient perspectives on cannabis use during treatmentKathy J Helzlsouer, Sonia M Rosenfield, Andrew N Freedman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 10, 2015
Opportunities for translational epidemiology: the important role of observational studies to advance precision oncologyMichael Marrone, Richard L Schilsky, Geoff Liu, et al.
Community Genetics|July 9, 2004
Awareness of genetic testing for increased cancer risk in the year 2000 National Health Interview SurveyLouise Wideroff, Susan Thomas Vadaparampil, Nancy Breen, et al.
Pharmacogenetics and Genomics|April 9, 2016
Dosing recommendations for pharmacogenetic interactions related to drug metabolismKelly K Filipski, Michael A Pacanowski, Anuradha Ramamoorthy, et al.
Cancer Causes & Control : CCC|October 2, 2009
The impact of changes in hormone therapy on breast cancer incidence in the US populationNathan J Coombs, Kathleen A Cronin, Richard J Taylor, et al.
JCO Precision Oncology|September 27, 2021
Distribution of Genomic Testing Resources by Oncology Practice and Rurality: A Nationally Representative StudyBrittany Gardner, Michelle Doose, Janeth I Sanchez, et al.
Expert Opinion on Drug Safety|July 8, 2014
Commonly used diabetes and cardiovascular medications and cancer recurrence and cancer-specific mortality: a review of the literatureJennifer W Wu, Denise M Boudreau, Yikyung Park, et al.
Plos Currents|June 7, 2014
Multi-marker Solid Tumor Panels Using Next-generation Sequencing to Direct Molecularly Targeted TherapiesMichael Marrone, Kelly K Filipski, Elizabeth M Gillanders, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 4, 2025
NCI-Funded Cancer Epidemiology Survivor Cohorts: Overview, Progress, and OpportunitiesLisa Gallicchio, Andrea N Burnett-Hartman, Kelly K Filipski, et al.
Pageof 7